Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Fournier

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2007
Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysisIrina Shahapuni, Najeh E L Esper, Roxana Opisiv, et al.
Stroke|January 7, 2006
Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?Albert Fournier, Gabriel Choukroun, Santhi Samy Modeliar, et al.
Current Pharmaceutical Design|October 28, 2005
The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotectionLaurent Magy, François Vincent, Sebastien Faure, et al.
Current Hypertension Reports|May 7, 2004
Is the angiotensin II Type 2 receptor cerebroprotective?Albert Fournier, Jean Michel Achard, Florent Boutitie, et al.
Stroke|September 16, 2006
AT1 receptor blockers for cognition decline after cardiac surgery?Roxana Oprisiu-Fournier, Jean-Marie Serot, Jean-Michel Achard, et al.
Nature Clinical Practice. Nephrology|August 26, 2006
Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patientsMatthieu Monge, Irina Shahapuni, Roxana Oprisiu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 14, 2005
Cinacalcet and vascular calcifications induced by calcitriolMatthieu Monge, Irina Shahapuni, Laïd Harbouche, et al.
The American Journal of Medicine|May 3, 2003
Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutationJean-Michel Achard, David G Warnock, Sandra Disse-Nicodème, et al.
Journal of Hypertension|July 11, 2007
Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin IIFlorent Boutitie, Roxana Oprisiu, Jean Michel Achard, et al.
Nephrologie & Therapeutique|June 2, 2007
[Which optimal antihypertensive bitherapy for kidney patients?]Jean-François Bonne, Irina Shahapuni, Sébastien Mailliez, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2007
Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysisIrina Shahapuni, Najeh E L Esper, Roxana Opisiv, et al.
Stroke|January 7, 2006
Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?Albert Fournier, Gabriel Choukroun, Santhi Samy Modeliar, et al.
Current Pharmaceutical Design|October 28, 2005
The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotectionLaurent Magy, François Vincent, Sebastien Faure, et al.
Current Hypertension Reports|May 7, 2004
Is the angiotensin II Type 2 receptor cerebroprotective?Albert Fournier, Jean Michel Achard, Florent Boutitie, et al.
Stroke|September 16, 2006
AT1 receptor blockers for cognition decline after cardiac surgery?Roxana Oprisiu-Fournier, Jean-Marie Serot, Jean-Michel Achard, et al.
Nature Clinical Practice. Nephrology|August 26, 2006
Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patientsMatthieu Monge, Irina Shahapuni, Roxana Oprisiu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 14, 2005
Cinacalcet and vascular calcifications induced by calcitriolMatthieu Monge, Irina Shahapuni, Laïd Harbouche, et al.
The American Journal of Medicine|May 3, 2003
Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutationJean-Michel Achard, David G Warnock, Sandra Disse-Nicodème, et al.
Journal of Hypertension|July 11, 2007
Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin IIFlorent Boutitie, Roxana Oprisiu, Jean Michel Achard, et al.
Nephrologie & Therapeutique|June 2, 2007
[Which optimal antihypertensive bitherapy for kidney patients?]Jean-François Bonne, Irina Shahapuni, Sébastien Mailliez, et al.
Pageof 8